Foundation Medicine Appoints Dan Malarek as Chief Executive Officer
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Foundation Medicine, Inc., today announced the appointment of Roche executive, Dan Malarek, as Chief Executive Officer... Read more.
Amide Technologies Announces Complex Peptide Manufacturing Platform, Raises $16.5M to Expedite Frontier Drug Discovery
Spun out of MIT, Amide partners with biopharmas to accelerate peptide drug development – shortening synthesis to days instead of months – with peptides... Read more.
Neochromosome Announces Collaboration with University of Edinburgh Creating Defined Variant Libraries for Designer Enzymes
Novel AI tool improved design of engineered enzymes and has potential to streamline development of drug candidates for genetic diseases Funding support for the project... Read more.
Airspeeder, Veritone and base Revolutionise eVTOL Racing Series With Digital Media Hub Partnership
LONDON–(BUSINESS WIRE)–Airspeeder, the world’s first racing series for crewed electric flying cars, has partnered with Veritone Inc. (NASDAQ: VERI),... Read more.
KKR Appoints Dane E. Holmes as Chief Administrative Officer
NEW YORK–(BUSINESS WIRE)–KKR today announced the appointment of Dane E. Holmes as Chief Administrative Officer (CAO), effective December 29, 2023. As... Read more.
Algbra Announces New World Group’s Adam Sadiq to its Board of Directors
LONDON–(BUSINESS WIRE)–Algbra, the UK FCA licensed fintech and global digital financial infrastructure company that offers its full-stack proprietary... Read more.
Global Internet of Things (IoT) in Defense Thematic Intelligence Report 2023: IoT and the OODA Loop, Enhancing Decision-Making in Defense – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Internet of Things (IoT) in Defense – Thematic Intelligence” report has been added to ResearchAndMarkets.com’s... Read more.
Bynder appoints Dominique LeBlond as Chief Product Officer
AMSTERDAM–(BUSINESS WIRE)–Bynder, the global leader in Digital Asset Management (DAM), is pleased to announce the appointment of Dominique LeBlond as... Read more.
ZURZUVAE™ (zuranolone) CIV, a Landmark Oral Treatment for Women with Postpartum Depression (PPD), is Now Available in the U.S.
ZURZUVAE, the first and only oral, once-daily, 14-day treatment course, has shown to provide rapid improvements in depressive symptoms at Day 15 and as early as... Read more.
Fisker Offers Financing as Low as 1.99% APR to US Customers Through Fisker FinanceSM
Fisker FinanceSM offers top qualified buyers in the U.S. access to vehicle financing at rates as low as 1.99% APR for 60 months Selected U.S. buyers can qualify... Read more.